Decision-making in the multiphase optimization strategy: Applying decision analysis for intervention value efficiency to optimize an information leaflet to promote key antecedents of medication adherence
Translational Behavioral Medicine · 2024
DOI: 10.1093/tbm/ibae029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Behavioral Medicine, 2024. Verfasst von Sophie M C Green und 3 weiteren Autor:innen. Beteiligte Einrichtung: Behavioural Oncology Research Group, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK. Hauptthemen laut MEDLINE: Breast Neoplasms, Medication Adherence, Bayes Theorem, Decision Support Techniques. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health Research.
Abstract (Originalsprache)
Advances in the multiphase optimization strategy (MOST) have suggested a new approach, decision analysis for intervention value efficiency (DAIVE), for selecting an optimized intervention based on the results of a factorial optimization trial. The new approach opens possibilities to select optimized interventions based on multiple valued outcomes. We applied DAIVE to identify an optimized information leaflet intended to support eventual adherence to adjuvant endocrine therapy for women with breast cancer. We used empirical performance data for five candidate leaflet components on three hypothesized antecedents of adherence: beliefs about the medication, objective knowledge about AET, and satisfaction with medication information. Using data from a 25 factorial trial (n = 1603), we applied the following steps: (i) We used Bayesian factorial analysis of variance to estimate main and interaction effects for the five factors on the three outcomes. (ii) We used posterior distributions for main and interaction effects to estimate expected outcomes for each leaflet version (32 total). (iii) We scaled and combined outcomes using a linear value function with predetermined weights indicating the relative importance of outcomes. (iv) We identified the leaflet that maximized the value function as the optimized leaflet, and we systematically varied outcome weights to explore robustness. The optimized leaflet included two candidate components, side-effects, and patient input, set to their higher levels. Selection was generally robust to weight variations consistent with the initial preferences for three outcomes. DAIVE enables selection of optimized interventions with the best-expected performance on multiple outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Behavioural Oncology Research Group, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
- Department of Social and Behavioral Sciences, New York University School of Global Public Health, New York, NY, USA.
ORCID-Profile: Sophie M C Green
Förderung
- National Institute for Health Research
Zitieren
APA
Green, S. M. C., Smith, S. G., Collins, L. M., & Strayhorn, J. C. (2024). Decision-making in the multiphase optimization strategy: Applying decision analysis for intervention value efficiency to optimize an information leaflet to promote key antecedents of medication adherence. Translational Behavioral Medicine. https://doi.org/10.1093/tbm/ibae029
Vancouver
Green SMC, Smith SG, Collins LM, Strayhorn JC. Decision-making in the multiphase optimization strategy: Applying decision analysis for intervention value efficiency to optimize an information leaflet to promote key antecedents of medication adherence. Translational Behavioral Medicine. 2024. doi:10.1093/tbm/ibae029
BibTeX
@article{Green2024,
author = {Green, Sophie M C and Smith, Samuel G and Collins, Linda M and Strayhorn, Jillian C},
title = {Decision-making in the multiphase optimization strategy: Applying decision analysis for intervention value efficiency to optimize an information leaflet to promote key antecedents of medication adherence},
journal = {Translational Behavioral Medicine},
year = {2024},
doi = {10.1093/tbm/ibae029}
}
EUVIMED